Ownership history in HighMark Wealth Management LLC · 10 quarters on record
This page tracks every 13F SEC filing in which HighMark Wealth Management LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 287 | — | 0% | 0.00% | $37 | — |
| 2025 Q2 | UNCHANGED | 287 | — | 0% | 0.00% | $69 | — |
| 2025 Q1 | UNCHANGED | 287 | — | 0% | 0.00% | $57 | — |
| 2024 Q4 | UNCHANGED | 287 | — | 0% | 0.00% | $155 | — |
| 2024 Q3 | UNCHANGED | 287 | — | 0% | 0.00% | $273 | — |
| 2024 Q2 | UNCHANGED | 287 | — | 0% | 0.00% | $280 | — |
| 2024 Q1 | UNCHANGED | 287 | — | 0% | 0.00% | $453 | — |
| 2023 Q4 | UNCHANGED | 287 | — | 0% | 0.00% | $228 | — |
| 2023 Q3 | REDUCED | 287 | -982 | -77.4% | 0.00% | $224 | — |
| 2023 Q2 | INITIATED | 1,269 | — | — | 0.00% | $1K | — |
As of 2025 Q4 — sorted by position size